Delivery Order SPE2DB24D1205-SPE2DB25FCQYE
Award Date
10/21/24
Potential Completion Date
11/12/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,399.71 firm-fixed-price delivery order is for the supply of the medication ZEPOSIA 0.92 MG CAPSULE 30S. The contract has an ultimate completion date of December 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,862.79 firm fixed-price delivery order contract is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,399.71 firm-fixed-price delivery order contract is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of November 22, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,241.86 firm fixed-price delivery order is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a specialty medication, to support military healthcare programs. The contract has an ultimate completion date of February 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $8,933.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of ZEPOSIA 0.92 MG CAPSULE 30S. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $13,399.71, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the delivery of ZEPOSIA 0.92 MG CAPSULE 30S. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of August 8, 2024. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $13,399.71 firm-fixed-price delivery order contract is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of October 1, 2024. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies,...
This contract award from the Defense Logistics Agency (DLA) is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of ZEPOSIA 0.92 MG CAPSULE 30S. The contract, valued at $13,862.79, is a Firm Fixed Price Delivery Order with a period of performance through December 23, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $13,399.71, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a prescription medication. The contract has a Firm Fixed Price pricing type and an ultimate completion date of November 14, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,466.57 firm fixed-price delivery order is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a specialty medication. The contract has an ultimate completion date of November 14, 2024 and was awarded on October 23, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...